β-Ionone Shows Promise in Preventing Ulcerative Colitis Through Gut Barrier Protection and Microbiota Regulation
en-GBde-DEes-ESfr-FR

β-Ionone Shows Promise in Preventing Ulcerative Colitis Through Gut Barrier Protection and Microbiota Regulation

14/12/2024 TranSpread

The research demonstrates that β-ionone can alleviate UC symptoms in mice by protecting the gut barrier and restoring the gut microbiota, offering hope for future dietary supplements or therapeutics aimed at managing UC.

Ulcerative colitis is an immune-mediated condition characterized by chronic inflammation of the colon. It is associated with dysbiosis of the gut microbiota, intestinal barrier dysfunction, and an imbalance in immune responses. Current treatments, including steroids and immunosuppressants, carry risks of side effects such as infections and organ damage. There is a pressing need for safer, more effective therapies. Recent studies have pointed to the gut microbiota as a key player in UC development, with emerging evidence suggesting that restoring microbial balance and supporting gut integrity could offer therapeutic benefits.

A study (DOI:10.48130/fia-0024-0031) published in Food Innovation and Advances on 22 October 2024 by Tao Tong’s team, China Agricultural University, provides a strong rationale for exploring β-ionone as a preventive or adjunctive therapy in UC treatment.

In this study, the researchers investigated the preventive effects of β-ionone (ION) on ulcerative colitis (UC) using a dextran sulfate sodium (DSS)-induced colitis mouse model. The colitis was induced by administering 1.5% DSS to mice, which led to significant symptoms including weight loss, diarrhea, and mucosal damage. Mice treated with ION showed significantly improved clinical outcomes, including lower disease activity index (DAI), reduced weight loss, and less colon shortening. Histological analysis revealed that ION treatment significantly reduced inflammatory cell infiltration and mucosal injury. The study also assessed pro-inflammatory cytokine levels, showing that ION supplementation effectively reduced the elevated expression of TNF-α and IL-8 induced by DSS. To evaluate oxidative stress, the study measured the levels of antioxidant enzymes (SOD and CAT) and malondialdehyde (MDA) in the colon tissues. The results showed that DSS treatment led to oxidative damage, which was mitigated by ION supplementation, as it reversed the decline in antioxidant enzyme activities and reduced MDA levels. Moreover, ION also influenced lipid metabolism, restoring abnormal serum lipid levels (TG, LDL-C, HDL-C) caused by DSS. Additionally, the study explored ION’s effects on the intestinal barrier, finding that ION enhanced mucin secretion and increased the expression of tight junction proteins (ZO-1 and occludin), thus improving the intestinal mucosal barrier. The study also demonstrated that ION reshaped the gut microbiota, restoring the diversity and composition of gut microbes altered by DSS. Specifically, ION increased the relative abundance of beneficial bacteria like Bacteroides and Faecalibaculum, and reduced harmful bacteria such as Parabacteroides. These results suggest that ION exerts its protective effects on UC by strengthening the gut barrier and modulating the gut microbiota, offering promising therapeutic potential for UC management.

This study provides compelling evidence that β-ionone can alleviate the symptoms of ulcerative colitis by protecting the intestinal barrier and modulating the gut microbiota. These findings lay the groundwork for future clinical research that could pave the way for new, natural-based therapies to prevent and manage UC, offering an alternative to current drug treatments that come with significant side effects.

###

References

DOI

10.48130/fia-0024-0031

Original Source URL

https://doi.org/10.48130/fia-0024-0031

Funding information

This research was funded by the Science and Technology project of Xizang Autonomous Region (XZ202401ZY0092) and Chinese Universities Scientific Fund (2024TC083).

About Food Innovation and Advances

Food is essential to life and relevant to human health. The rapidly increasing global population presents a major challenge to supply abundant, safe, and healthy food into the future. The open access journal Food Innovation and Advances (e-ISSN 2836-774X), published by Maximum Academic Press in association with China Agricultural University, Zhejiang University and Shenyang Agricultural University, publishes high-quality research results related to innovations and advances in food science and technology. The journal will strive to contribute to food sustainability in the present and future.

Title of original paper: β-ionone prevents dextran sulfate sodium-induced ulcerative colitis and modulates gut microbiota in mice
Authors: Jingjing Fang1#, Tingting Liu1#, Yumeng Wang1, Seong-Gook Kang2, Kunlun Huang1,3,4 and Tao Tong1,3,4
Journal: Food Innovation and Advances
Original Source URL: https://www.maxapress.com/article/doi/10.48130/fia-0024-0031
DOI: 10.48130/fia-0024-0031
Latest article publication date: 22 October 2024
Subject of research: Not applicable
COI statement: The authors declare that they have no competing interests.
Attached files
  • Figure 5. ION supplementation changes the key phylotypes and function of the gut microbiota of UC mice. (a) LEfSe analysis (the rings, from inner to outer: phylum, class, order, family, and genus). (b) Gut microbiota between CON, DSS, and ION groups with LDA score > 4 and p < 0.05. (c) Comparison of KEGG pathways in the CON and DSS groups. (d) Comparison of KEGG pathways in the ION and DSS groups.
14/12/2024 TranSpread
Regions: North America, United States, Asia, China
Keywords: Applied science, Engineering, Science, Agriculture & fishing

Disclaimer: AlphaGalileo is not responsible for the accuracy of news releases posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Testimonials

For well over a decade, in my capacity as a researcher, broadcaster, and producer, I have relied heavily on Alphagalileo.
All of my work trips have been planned around stories that I've found on this site.
The under embargo section allows us to plan ahead and the news releases enable us to find key experts.
Going through the tailored daily updates is the best way to start the day. It's such a critical service for me and many of my colleagues.
Koula Bouloukos, Senior manager, Editorial & Production Underknown
We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet

We Work Closely With...


  • BBC
  • The Times
  • National Geographic
  • The University of Edinburgh
  • University of Cambridge
  • iesResearch
Copyright 2024 by AlphaGalileo Terms Of Use Privacy Statement